2013
DOI: 10.1016/j.ijmedinf.2013.02.001
|View full text |Cite
|
Sign up to set email alerts
|

Assessment of efficiency and safety of the comprehensive Chemotherapy Assistance Program for ordering oncology medications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
6
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(6 citation statements)
references
References 44 publications
0
6
0
Order By: Relevance
“…Although errors were defined differently across studies, prescription errors were reduced in each of the 9 studies. 20,2325,2731 One study evaluated medication-related safety events, demonstrating fewer events with use of CDS. 22 Two studies evaluated pharmacy work flow, with one study showing decreased workflow fragmentation and increased continuous task time with CPOE, 26 while another study showed increased order review time with CPOE.…”
Section: Resultsmentioning
confidence: 99%
“…Although errors were defined differently across studies, prescription errors were reduced in each of the 9 studies. 20,2325,2731 One study evaluated medication-related safety events, demonstrating fewer events with use of CDS. 22 Two studies evaluated pharmacy work flow, with one study showing decreased workflow fragmentation and increased continuous task time with CPOE, 26 while another study showed increased order review time with CPOE.…”
Section: Resultsmentioning
confidence: 99%
“…Theirs was the final unit at the center to adopt CPOE and required "considerable effort" to develop a customized implementation. Other studies have demonstrated similar results using various commercial and in-house developed systems [19][20][21]. A CPOE system was safely implemented at St. Jude Children's Research Hospital in 2010 after technical improvements addressed safety issues [22].…”
Section: Introductionmentioning
confidence: 73%
“…As suggested by Cho et al ., another underlying cause could be the complexity involved in completely fitting a CPOE system into oncohaematological medication schemes and practice. Although one study showed that 77·7% of MEs remained 3 years after implementing CPOE, it did not analyse the medication‐use process associated with antineoplastic agents and so caution should be exercised when comparing this study and the present study.…”
Section: Resultsmentioning
confidence: 99%